Low Grade Serous Carcinoma clinical trials at University of California Health

1 research study open to eligible people

Showing trials for

  • Ribociclib and Letrozole Treatment in Ovarian Cancer

    open to eligible females ages 18 years and up

    The study evaluates the response to treatment with Ribociclib and Letrozole in patients with low grade serous cancer of the ovary, fallopian tube or peritoneum.

    at UCSF

Our lead scientists for Low Grade Serous Carcinoma research studies include .

Last updated: